oncolytic

Also found in: Medical, Encyclopedia, Wikipedia.

oncolytic

(ˌɒŋkəˈlɪtɪk)

adj

(Biology) absorbing or destroying tumours

References in periodicals archive ?

Merck known as MSD outside the United States and Canada, and Viralytics Limited today announced that the companies have signed a definitive agreement under which it is proposed that Merck, through a subsidiary, will acquire Viralytics, an Australian publicly traded company focused on oncolytic immunotherapy treatments for a range of cancers by way of a scheme of arrangement (Scheme) for AUD 1.

Canada,United States : Merck and Viralytics Announce Acquisition Agreement, Expanding Mercks Leading Immuno-Oncology Pipeline

M2 EQUITYBITES-January 23, 2018-SillaJen expands partnership with ABL Europe for oncolytic virus therapies JX-594 & JX-970

SillaJen expands partnership with ABL Europe for oncolytic virus therapies JX-594 & JX-970

M2 PHARMA-January 23, 2018-SillaJen expands partnership with ABL Europe for oncolytic virus therapies JX-594 & JX-970

SillaJen expands partnership with ABL Europe for oncolytic virus therapies JX-594 & JX-970

Oncolytic viruses have the power of directly lysing cancer cells, and they also free tumor-specific neoantigents, as they can indirectly act as a cancer vaccine.

New Immunotherapy Report Package by La Merie Publishing Now Available at MarketPublishers.com

Transgene and Randox have entered into a collaboration to combine their technologies and develop multifunctional oncolytic immunotherapies.

TRANSGENE AND RANDOX DEVELOP OV'S FOR SOLID TUMORS

Our results are the first to provide insight into ways of targeting multiple brain metastatic deposits with stem cell-loaded oncolytic viruses that specifically kill dividing tumor cells.

Stem cell-based therapy may target skin-to-bram cancer

Virttu is focused on the development of oncolytic virus therapy for treatment of cancer.

Deal snapshot: SORRENTO'S TNK THERAPEUTICS UNIT CLOSES ACQUISITION OF SCOTTISH CANCER THERAPIES DEVELOPER VIRTTU BIOLOGICS

History of oncolytic viruses: genesis to genetic engineering.

Oncolytic viral therapy

Oncolytic viruses, with their long history of experimentation, have been deemed to be a key player in the future treatment of gliomas.

IS ONCOLYTIC VIROTHERAPY A VIABLE PLATFORM FOR GLIOMA TREATMENT?

Medivate Partners has closed a USD12 million investment in Sillajen, a global oncolytic immunotherapeutic firm currently in Phase III multi-national clinical development in US, Europe and Asia, the company said.

Medivate Partners invests USD12m in Sillajen

Treatment with the oncolytic immunotherapy talimogene laherparepvec (T-VEC) resulted in significantly longer rates of durable response and overall response, compared with subcutaneous granulocyte-macrophage colony-stimulating factor (GM-CSF), according to results from the phase III OPTiM trial reported in the Journal of Clinical Oncology.

T-VEC ups durable response rate in advanced melanoma

VSV-GP is a highly potent oncolytic virus that carries the surface protein from the lymphocytic choriomeningitis virus (LCMV).